Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sarcoma complicating therapy with cyclophosphamide

J S Marks, C L Scholtz

    Postgraduate Medical Journal
    |January 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Bilirubin levels in breast-fed infants.

    Canadian Medical Association journal·2010
    Same author

    Sexual behaviour: related adverse health burden in the United States.

    Sexually transmitted infections·2005
    Same author

    Allelic variation in the promoter region of the LDL receptor gene: analysis of an African-specific variant in the FP2 cis-acting regulatory element.

    Molecular and cellular probes·2003
    Same author

    Racial/ethnic disparities in mortality by stroke subtype in the United States, 1995-1998.

    American journal of epidemiology·2001
    Same author

    Chronic disease challenges present new opportunities for AAMC-CDC partnerships. Association of American Medical Colleges.

    Academic medicine : journal of the Association of American Medical Colleges·2001
    Same author

    The continuing epidemics of obesity and diabetes in the United States.

    JAMA·2001
    Same journal

    Comparative efficacy of Janus kinase inhibitors in severe alopecia areata: a network meta-analysis based on randomized controlled trials.

    Postgraduate medical journal·2026
    Same journal

    Two cases of toxic epidermal necrolysis with severe ocular involvement treated with adjunctive tofacitinib.

    Postgraduate medical journal·2026
    Same journal

    Diastolic dysfunction and diabetes: the DIADAD study-a retrospective cohort study from Liverpool.

    Postgraduate medical journal·2026
    Same journal

    Care, cash, and proof: forensic accountability for war-related starvation.

    Postgraduate medical journal·2026
    Same journal

    Response to traumatic injuries in polo players in England.

    Postgraduate medical journal·2026
    Same journal

    Aids to venesection and parenteral drug administration in patients with difficult veins.

    Postgraduate medical journal·2026
    See all related articles

    A patient developed sarcoma after cyclophosphamide treatment for rheumatoid arthritis. This highlights the risk of cancer with immunosuppressive drugs.

    Area of Science:

    • Oncology
    • Rheumatology
    • Immunology

    Background:

    • Rheumatoid arthritis is an autoimmune disease often treated with immunosuppressive agents.
    • Cyclophosphamide is an alkylating agent used in treating various conditions, including autoimmune diseases.

    Observation:

    • A case study details a patient with rheumatoid arthritis who received cyclophosphamide therapy.
    • The patient subsequently developed a poorly differentiated sarcoma.

    Findings:

    • The development of sarcoma occurred following cyclophosphamide administration.
    • This suggests a potential link between cyclophosphamide use and secondary malignancies.

    Implications:

    • Immunosuppressive drug therapy, including cyclophosphamide, may increase the risk of neoplastic disease.

    Related Experiment Videos

  • Clinicians should consider the potential for secondary cancers when prescribing long-term immunosuppression.
  • Further research is warranted to elucidate the oncogenic potential of immunosuppressive agents.